glp 1 agonists approved for weight loss GLP-1 Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Skyrocketing Popularity Puts GLP-1 Agonists

In transgenic models, it reduced fibril formation by 62% and striatal deposits by 41%, while also improving motor function without eliciting significant immunogenicity

Chakraborti S, Karmakar A, Guha R, Ngan C, Das RK, Whitaker N

They give you energy without making you feel sick

5.3.9 Regulation of glycolysis Artesunate and dihydroartemisinin downregulate the extracellular signal-regulated kinase activity, inhibit c-Myc expression, and decrease glucose transporter protein (GLUT1), human myosin-releasing enzyme (HK 2), and lactate dehydrogenase A concentrations in a dose-dependent manner

Ahadiat S-A, Hosseinian Z